Dubai Final-v20.indd - World Allergy Organization
Dubai Final-v20.indd - World Allergy Organization
Dubai Final-v20.indd - World Allergy Organization
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
EXHiBitOr DirECtOrY<br />
omron Healthcare Europe B.V. Booth 2<br />
Kruisweg 577<br />
Hoofddrop 2132 nA<br />
netherlands<br />
Phone: +31 20 354 8200<br />
Fax: +31 20 354 8201<br />
Website: www.omrom-healthcare.com<br />
Email: info.omronhealthcare@eu.omron.com<br />
Omron Healthcare, an innovative global medical devices company,<br />
develops and manufactures high quality products for respiratory care.<br />
Omron’s further product line is dedicated to preventing, monitoring<br />
and treating lifestyle-related diseases such as cardiovascular,<br />
hypertension, diabetes and obesity.<br />
Sanofi-aventis Booth 9<br />
182 Avenue de France<br />
Paris 75013<br />
France<br />
Phone: +33 1 55 71 51 76<br />
Fax: +33 1 55 71 51 80<br />
Website: www.sanofi-aventis.com<br />
telfast®/Allegra® (fexofenadine hydrochloride) is a selective,<br />
non-sedating, H1-receptor antagonist indicated in seasonal Allergic<br />
rhinitis and Chronic idiopathic Urticaria in children and adults. it does<br />
not cross the blood-brain barrier.<br />
nasacort® AQ (triamcinolone acetonide) nasal spray is indicated<br />
for the treatment of the nasal symptoms of seasonal and Perennial<br />
Allergic rhinitis in adults and children 2 years of age and older.<br />
Formulated with no fragrance and no alcohol.<br />
Before prescribing the product always refer to the prescribing<br />
information available in your country.<br />
Stallergenes Booth 4<br />
6 rue Alexis de tocqueville<br />
Antony 92183<br />
France<br />
Phone: +33 1 55 59 20 00<br />
Fax: +33 1 55 59 21 29<br />
Website: www.stallergenes.com<br />
Email: contact@stallergenes.com<br />
stallergenes is a European biopharmaceutical company dedicated to<br />
allergen immunotherapy for the prevention and treatment of allergyrelated<br />
respiratory diseases, e.g. allergic rhinitis, rhinoconjunctivitis<br />
and asthma.<br />
leader in sublingual immunotherapy treatments, stallergenes<br />
reached a turnover of 193 million euros in 2009 (24%, being devoted<br />
to research and Development) and is actively involved in the<br />
development of sublingual immunotherapy tablets.<br />
stallergenes markets its products in 50 countries via 10 subsidiaries<br />
throughout Europe and distribution and partnership agreements<br />
around the globe.<br />
WAO IntErnAtIOnAl ScIEntIfIc cOnfErEncE<br />
Asthma and Co-morbid Conditions: Expanding the Practice of <strong>Allergy</strong> for Optimal Patient Care<br />
<strong>World</strong> allergy organization (Wao)<br />
555 East Wells street, suite 1100<br />
milwaukee, Wi 53202<br />
UsA<br />
Phone: +1 414 276 1791<br />
Fax: +1 414 276 3349<br />
Email: info@worldallergy.org<br />
Website: www.worldallergy.org<br />
Please visit the WAO Exhibit to learn more about WAO: Educational<br />
Programs, Online learning, and the <strong>World</strong> <strong>Allergy</strong> <strong>Organization</strong><br />
Journal (WAOJ)<br />
2011 <strong>World</strong> allergy Congress (WaC)<br />
555 East Wells street, suite 1100<br />
milwaukee, Wi 53202<br />
UsA<br />
Phone: +1 414 276 1791<br />
Fax: +1 414 276 3349<br />
Email: WAC2011@worldallergy.org<br />
Website: www.worldallergy.org/wac2011<br />
Please visit the WAC Exhibit to learn more about the 2011 <strong>World</strong> <strong>Allergy</strong><br />
Congress from 4 – 8 December in Cancún, méxico and receive a<br />
special registration discount code for use by 1 January 2011.<br />
www.worldallergy.org 26<br />
FinAl PrOgrAm
Change language